百龙创园：拟以1000万元在南京投资设立全资子公司南京百龙

Core Viewpoint - The company, Bailong Chuangyuan, announced the establishment of a wholly-owned subsidiary, Bailong Chuangyuan (Nanjing) Biotechnology Co., Ltd., with an investment of 10 million RMB to enhance its international market presence and sales team [1] Group 1 - The investment aims to strengthen the overseas sales team and actively explore international markets [1] - The establishment of the Nanjing subsidiary will facilitate the recruitment of international trade talent and leverage Nanjing's geographical advantages to expand overseas customer outreach and technical exchanges [1] - This initiative is expected to increase the company's export revenue and enhance its service capabilities for overseas clients, thereby improving overall profitability [1]